This novel miR-137/PAQR3 axis may provide new insights into the mechanisms underlying tumor metastasis, and repression of miR-137 expression may be a potential therapeutic strategy for the treatment of bladder cancer in the future. The gene discussed is PAQR3; the disease is urinary bladder carcinoma.